Skip to main content
Premium Trial:

Request an Annual Quote

Iconix Wins EPA Contract for Chemogenomics-Based Toxicity Screens

NEW YORK, Jan. 6 (GenomeWeb News) - Iconix Pharmaceuticals has won a contract from the Environmental Protection Agency to screen chemicals for toxicity using its chemogenomics platform, the company said today.


Iconix, based in Mountain View, Calif., will use its DrugMatrix platform to work work with the EPA's Computational Toxicology Research Program to study the potential toxicity of five undisclosed chemicals.


DrugMatrix contains profiles of more than 650 chemical compounds, including information about gene expression, biological pathways, toxicology, and pharmacology.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.